Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Claritin-D 24 Hour Loratadine and pseudoephedrine sulfate 10 mg; 240 mg Tablet, Extended Release — NDC 11523-4332-3 (Billing 11523-4332-03)
by Bayer HealthCare LLC. · 3 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
This is a package of Claritin-D 24 Hour Loratadine and pseudoephedrine sulfate 10 mg; 240 mg Tablet, Extended Release from Bayer HealthCare LLC., no longer marketed (first marketed Dec 2009), no longer in the FDA NDC Directory.
NDC 11523-4332-03
🏷️ FDA NDC (as labeled)
11523-4332-3
billing pads the package segment with a zero
This package
Contains5 tablet, extended release in 1 blister pack
Pack sizes3 compare ↓
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 11523-4332-3 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 11523 labeler · 4332 product · 3 package
- Package marketed since
- Dec 1, 2009
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC)
- 0041100810861
- FDA record last changed
- Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Nov 2022. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
11523-4332-3
Product NDC
11523-4332
11-digit billing NDC
11523433203
NCPDP billing unit
EA — each (per item)
UNII
7AJO3BO7QN, Y9DL7QPE6B
UPC
0041100810861
Application #
NDA020470
SPL Set ID
f046a807-ab8c-0620-e053-2a95a90a9d3c
Established class (EPC)
alpha-Adrenergic Agonist
Mechanism of action
Adrenergic alpha-Agonists
DEA schedule
Non-controlled
Marketing category
NDA
Marketing status
Discontinued
FDA listing status
Discontinued by firm (certified through Nov 2022)
Marketing start
2009-12-01
Route
ORAL
Dosage form
TABLET, EXTENDED RELEASE
Substance
LORATADINE; PSEUDOEPHEDRINE SULFATE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
43993002597520
GPI class
Claritin-D 24 Hour
GCN Seq No
027622
GCN
63577
HICL code
006605
Ingredient (HICL)
Loratadine/Pseudoephedrine
HIC1 code
Z
Therapeutic class — broad (HIC1)
Body As A Whole
HIC2 code
Z2
Therapeutic class — intermediate (HIC2)
Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code
Z2O
Therapeutic class — specific (HIC3)
2Nd Gen Antihistamine And Decongestant Combination
AHFS code
04:08.00.00
AHFS class
Second Generation Antihistamines
FDB label name
CLARITIN-D 24 HOUR TABLET
FDB brand name
Claritin-D 24 Hour
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 027622
- GCN: 63577
- GPI-14 (Medi-Span): 43993002597520
- HICL (First Databank): 006605
- AHFS class code: 04:08.00.00
- RxCUI (RxNorm): 1117562
Why two NDCs?
The FDA registers this code as 11523-4332-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 11523-4332-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 5, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Other antihistamines for systemic use class.
Drug family (ATC)
Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Label name CLARITIN-D 24 HOUR TABLET Ingredient Loratadine/Pseudoephedrine
📗 Our plain-language guide HelloPharmacist
- It temporarily relieves allergy symptoms like sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat. It also relieves nasal and sinus congestion from allergie...
- Swallow the tablet whole with a full glass of water. Never split, crush, chew or dissolve it. Some products are once a day and others are every 12 hours, so check your box and foll...
- Not if it is an MAOI, or if you stopped one within the last 2 weeks. MAOIs are used for certain depression, psychiatric conditions, and Parkinson's disease. If you are unsure, ask...
- Taking more than directed may cause drowsiness. Nervousness, dizziness or trouble sleeping can happen too. If any of these occur, stop and talk with your doctor.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 5, 2026
💬 Questions about Loratadine and pseudoephedrine sulfate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 5, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 11523-4332-01 11523-4332-1 Main listing | 1 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 2009-12-01 | — | Discontinued by firm |
| 11523-4332-02 11523-4332-2 | 1 BLISTER PACK in 1 CARTON / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 2009-12-01 | — | Discontinued by firm |
| 11523-4332-03 You're viewing this | 3 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 2009-12-01 | — | Discontinued by firm |
Pack size FAQ
What quantity is in this package?
This package is listed by the FDA — 3 blister pack in 1 carton / 5 tablet, extended release in 1 blister pack.
What NDC number is used to bill for this package of Claritin-D 24 Hour Loratadine and pseudoephedrine sulfate 10 mg; 240 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| allergy d 10 mg/1; 240 mg 00113-9004-22 | L. | 1 tablet | $0.553 | — | Availability likely | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 00904-5833-15 | Major | 10 tablets | $0.553 | — | Availability likely | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 46122-0167-52 | Amerisource | 10 tablets | $0.553 | — | Availability likely | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 46122-0383-22 | AMERISOURCE | 15 tablets | $0.553 | — | Availability likely | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 51660-0724-04 | Ohm | 5 tablets | $0.553 | — | Availability likely | — |
| Leader Allergy Relief D-24 10 mg/1; 240 mg 70000-0162-01 | Cardinal | 10 tablets | $0.553 | — | Availability likely | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 70677-1018-01 | STRATEGIC | 10 tablets | $0.553 | — | Availability likely | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49348-0543-01 | STRATEGIC | 10 tablets | $0.574 | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 62011-0071-01 | Strategic | 10 tablets | $0.574 | — | FDA listed | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 00363-0725-15 | Walgreen | 15 tablets | — | — | FDA listed | — |
| Allergy Relief D 10 mg/1; 240 mg 00363-2010-22 | Walgreen | 1 tablet | — | — | FDA listed | — |
| Claritin-D 24 Hour 10 mg/1; 240 mg 11523-0102-01 | Bayer | 10 tablets | — | — | FDA listed | — |
| Claritin-D 24 Hour 10 mg/1; 240 mgthis 11523-4332-03 | Bayer | 5 tablets | — | — | Discontinued | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 11822-9990-00 | Rite | 10 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 21130-0724-15 | Safeway | 15 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 30142-0724-15 | The | 1 tablet | — | — | FDA listed | — |
| allergy congestion relief 10 mg/1; 240 mg 30142-0846-22 | Kroger | 1 tablet | — | — | FDA listed | — |
| topcare allergy and congestion relief 10 mg/1; 240 mg 36800-0706-22 | Topco | 1 tablet | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0427-69 | HEB | 10 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0724-69 | HEB | 10 tablets | — | — | FDA listed | — |
| Allergy Relief-D 240 mg/1; 10 mg 37808-0787-07 | HEB | 5 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 41250-0724-52 | Meijer | 15 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49035-0488-15 | WAL-MART | 15 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 51660-0491-15 | Ohm | 15 tablets | — | — | Discontinued | — |
| Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 56062-0724-15 | Publix | 15 tablets | — | — | FDA listed | — |
| Allergy Relief-D 10 mg/1; 240 mg 59779-0726-15 | CVS | 5 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 63187-0305-10 | Proficient | 10 tablets | — | — | FDA listed | — |
| kirkland signature allerclear d 24 hr 10 mg/1; 240 mg 63981-0138-22 | Costco | 1 tablet | — | — | FDA listed | — |
| KIRKLAND SIGNATURE ALLERCLEAR D 24 HR Extended Release 10 mg/1; 240 mg 63981-0724-15 | Kirkland-COSTCO | 15 tablets | — | — | FDA listed | — |
| Loratadine and Pseudoephedrine 10 mg/1; 240 mg 85766-0048-10 | Sportpharm | 10 tablets | — | — | FDA listed | — |
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2009
On the market since
Dec 2009
📍
2026
Currently FDA-listed
17 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
white
ShapeRound
ImprintClaritin;D;24
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 5, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Loratadine / Pseudoephedrine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII O7TSZ97GEP
A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
-
UNII R12CBM0EIZ
A natural wax derived from a Brazilian palm tree, used as a coating and polish on tablets and capsules. It creates a smooth, shiny finish that protects the medicine and improves appearance.
-
UNII 7Z8S9VYZ4B
Ethylcellulose is a plant-derived thickener and film-former made by chemically modifying cellulose. It's used as a binder to hold tablet ingredients together, a coating to control how quickly medicine is released, or a thickener in liquid formulations.
-
UNII RFW2ET671P
Hydroxypropyl cellulose is a plant-derived thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a film-former to coat tablets or control how fast the medicine releases.
-
UNII 3NXW29V3WO
Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 3WJQ0SDW1A
Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
-
UNII FZ989GH94E
Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII C151H8M554
A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
11 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statescarnauba wax, dibasic calcium phosphate dihydrate, ethylcellulose, hydroxypropyl cellulose, hypromellose, magnesium stearate, pharmaceutical ink, polyethylene glycol, povidone, silicon dioxide, sucrose, titanium dioxide
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 5, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerBayer HealthCare LLC.
Application holderBAYER HEALTHCARE LLC
FDA applicationNDA020470 (NDA)
Labeler code11523
First marketedDec 2009
Product typeHuman Otc Drug
Portfolio240 products on file
More NDCs from Bayer HealthCare LLC. labeler code 11523
- Coricidin HBP Cold and Flu Acetaminophen and Chlorpheniramine maleate 325 mg; 2 mg Tablet, Film Coated NDC 11523-4325-1
- Coricidin HBP Cough and Cold Cough Suppressant, Antihistamine Chlorpheniramine maleate and Dextromethorphan hydrobromide 4 mg; 30 mg Tablet, Film Coated NDC 11523-4326-1
- Claritin Loratadine 5 mg Tablet, Chewable NDC 11523-4328-1
- Claritin Reditabs Loratadine 10 mg Tablet, Orally Disintegrating NDC 11523-4329-1
- Claritin loratadine 5 mg Tablet, Chewable NDC 11523-4330-1
- Claritin Loratadine 5 mg Tablet, Chewable NDC 11523-4331-1
- Lotrimin Ultra Athletes Foot Butenafine hydrochloride 1 g/100g Cream NDC 11523-4338-1
- Lotrimin Ultra Jock Itch Butenafine hydrochloride 1 g/100g Cream NDC 11523-4339-1
- MiraLAX Polyethylene Glycol 3350 3350 17 g/17g Powder, For Solution NDC 11523-4357-2
- Coricidin HBP Nighttime Multi-Symptom Cold Acetaminophen,Dextromethorphan hydrobromide, doxylamine succinate 6.25 mg/15mL; 325 mg/15mL; 15 mg/15mL Liquid NDC 11523-4358-1
- Claritin Loratadine 10 mg Tablet NDC 11523-4359-1
- Children Claritin Allergy loratadine 5 mg/5mL Solution NDC 11523-4360-1
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 Ask a Doctor Before Use If
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
🤰 If Pregnant or Breast-Feeding
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing itchy, watery eyes runny nose itching of the nose or throat temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose
⏱️ Dosage and Administration ▾
Directions do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor
⚠️ Warnings ▾
Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have heart disease thyroid disease high blood pressure diabetes trouble urinating due to an enlarged prostate gland liver or kidney disease.
Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever nervousness, dizziness or sleeplessness occurs If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information each tablet contains: calcium 25 mg safety sealed: do not use if the individual blister unit imprinted with Claritin-D ® 24 hour is open or torn store between 20° to 25°C (68° to 77°F) protect from light and store in a dry place
🧪 Active Ingredient ▾
Active ingredient (in each tablet) Purpose Loratadine 10 mg Antihistamine Pseudoephedrine sulfate 240 mg Nasal decongestant
🧪 Inactive Ingredients ▾
Inactive ingredients carnauba wax, dibasic calcium phosphate dihydrate, ethylcellulose, hydroxypropyl cellulose, hypromellose, magnesium stearate, pharmaceutical ink, polyethylene glycol, povidone, silicon dioxide, sucrose, titanium dioxide
🎯 Purpose ▾
Active ingredient (in each tablet) Purpose Loratadine 10 mg Antihistamine Pseudoephedrine sulfate 240 mg Nasal decongestant
📄 Do Not Use ▾
Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have heart disease thyroid disease high blood pressure diabetes trouble urinating due to an enlarged prostate gland liver or kidney disease. Your doctor should determine if you need a different dose.
📄 When Using This Product ▾
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever nervousness, dizziness or sleeplessness occurs
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Questions or comments? 1-800-CLARITIN (1-800-252-7484) or www.claritin.com
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 10 Tablet Blister Pack Carton NDC 11523-4332-1 Non-Drowsy * Claritin-D ® pseudoephedrine sulfate 240 mg/nasal decongestant loratadine 10 mg/antihistamine Indoor & Outdoor Allergies Allergy & Congestion 24 Hour Relief of: Nasal & Sinus Congestion Due to Colds or Allergies Sneezing; Runny Nose; Itchy, Watery Eyes; Itchy Throat or Nose Due to Allergies * When taken as directed. See Drug Facts Panel. 5 EXTENDED RELEASE TABLETS PDP PDP
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Claritin-D 24 Hour (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 30%
Female · 69%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 5 tablets (11523-4332-01), 10 tablets (11523-4332-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Bayer HealthCare LLC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.